Paper39550359
Broad-spectrum inflammasome inhibition by thiomuscimol.
Anderson MJ and 3 others. Cell Death Discov, 2024. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Broad-spectrum inflammasome inhibition by thiomuscimol. Papers, record 39550359. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39550359
- Cell line
- NCTC clone 92991 papers
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Source Cell lines
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| S10 OD016240 | NIH HHS | United States | S10OD016240 | PubMed and NIH | NIH RePORTER |
| R21AI178367 | U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) | R21AI178367 | PubMed and NIH | NIH RePORTER | |
| R01AI162684 | U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) | R01AI162684 | PubMed and NIH | NIH RePORTER | |
| R01 AI162684 | NIAID NIH HHS | United States | R01AI162684 | PubMed and NIH | NIH RePORTER |
| R21 AI178367 | NIAID NIH HHS | United States | R21AI178367 | PubMed and NIH | NIH RePORTER |
References53
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35185469 | Crosstalk Between the NLRP3 Inflammasome/ASC Speck and Amyloid Protein Aggregates Drives Disease Progression in Alzheimer's and Parkinson's Disease. | Front Mol Neurosci | 2022 | https://conductscience.org/library/papers/35185469 | PubMed |
| 2 | 32713036 | AIM2 in health and disease: Inflammasome and beyond. | Immunol Rev | 2020 | https://conductscience.org/library/papers/32713036 | PubMed |
| 3 | 22555457 | AIM2/ASC triggers caspase-8-dependent apoptosis in Francisella-infected caspase-1-deficient macrophages. | Cell Death Differ | 2012 | https://conductscience.org/library/papers/22555457 | PubMed |
| 4 | 31064994 | Caspase-1 initiates apoptosis in the absence of gasdermin D. | Nat Commun | 2019 | https://conductscience.org/library/papers/31064994 | PubMed |
| 5 | 38374299 | Mechanistic insights from inflammasome structures. | Nat Rev Immunol | 2024 | https://conductscience.org/library/papers/38374299 | PubMed |
| 6 | 27197150 | Novel Protein Disulfide Isomerase Inhibitor with Anticancer Activity in Multiple Myeloma. | Cancer Res | 2016 | https://conductscience.org/library/papers/27197150 | PubMed |
| 7 | 34373622 | Inflammasome activation at the crux of severe COVID-19. | Nat Rev Immunol | 2021 | https://conductscience.org/library/papers/34373622 | PubMed |
| 8 | 25621709 | The NAIP/NLRC4 inflammasomes. | Curr Opin Immunol | 2015 | https://conductscience.org/library/papers/25621709 | PubMed |
| 9 | 29718184 | The pyrin inflammasome: from sensing RhoA GTPases-inhibiting toxins to triggering autoinflammatory syndromes. | Pathog Dis | 2018 | https://conductscience.org/library/papers/29718184 | PubMed |
| 10 | 38324950 | The research progression of direct NLRP3 inhibitors to treat inflammatory disorders. | Cell Immunol | 2024 | https://conductscience.org/library/papers/38324950 | PubMed |
| 11 | 39324136 | The role of inflammasomes as central inflammatory hubs in Mycobacterium tuberculosis infection. | Front Immunol | 2024 | https://conductscience.org/library/papers/39324136 | PubMed |
| 12 | 27346360 | A Fluorescent Reporter Mouse for Inflammasome Assembly Demonstrates an Important Role for Cell-Bound and Free ASC Specks during In Vivo Infection. | Cell Rep | 2016 | https://conductscience.org/library/papers/27346360 | PubMed |
| 13 | 37437353 | Pyroptosis and the cellular consequences of gasdermin pores. | Semin Immunol | 2023 | https://conductscience.org/library/papers/37437353 | PubMed |
| 14 | 28009077 | Inflammasomes as therapeutic targets for Alzheimer's disease. | Brain Pathol | 2017 | https://conductscience.org/library/papers/28009077 | PubMed |
| 15 | 24684968 | Anthrax lethal and edema toxins in anthrax pathogenesis. | Trends Microbiol | 2014 | https://conductscience.org/library/papers/24684968 | PubMed |
| 16 | 34903717 | Identification of an ASC oligomerization inhibitor for the treatment of inflammatory diseases. | Cell Death Dis | 2021 | https://conductscience.org/library/papers/34903717 | PubMed |
| 17 | 24492532 | Activation of the NLRP1b inflammasome independently of ASC-mediated caspase-1 autoproteolysis and speck formation. | Nat Commun | 2014 | https://conductscience.org/library/papers/24492532 | PubMed |
| 18 | 33850310 | An update on the regulatory mechanisms of NLRP3 inflammasome activation. | Cell Mol Immunol | 2021 | https://conductscience.org/library/papers/33850310 | PubMed |
| 19 | 35193437 | The importance of sulfur-containing motifs in drug design and discovery. | Expert Opin Drug Discov | 2022 | https://conductscience.org/library/papers/35193437 | PubMed |
| 20 | 37633753 | Inflammasome assembly in neurodegenerative diseases. | Trends Neurosci | 2023 | https://conductscience.org/library/papers/37633753 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42662069 | Decoding the molecular mechanisms of pyroptosis and its therapeutic development prospects. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42662069 | PubMed |
| 42653238 | Structure-Activity Relationship for Inflammasome Inhibition by Thiomuscimol. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42653238 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CASP1 | 834 | PubTator's text mining | https://conductscience.org/library/genes/834 | NCBI Gene |
| PYCARD | 29108 | PubTator's text mining | https://conductscience.org/library/genes/29108 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39550359
GET https://conductscience.org/api/papers/v1/39550359/references?page=2